May 30 (Reuters) - Spectral Medical Inc EDT.TO :
* Spectral Medical- submitted fourth and final module of its PMA application to U.S. FDA based on further analysis of euphrates trial Source text for Eikon: ID:nMKW7KJ3va Further company coverage: EDT.TO